Community-based Brain Health Program to Address Dementia Risk
| 対象疾患 | Dementia, Alzheimer Disease |
|---|---|
| 相 | 該当なし |
| スポンサー | Posit Science Corporation |
| ステータス | 完了 |
| 参加者数 | 86 名 |
| 介入(薬剤) | Brain Health Program |
| 開始日 | 2023年4月24日 |
| 完了日 | 2024年10月18日 |
| 結果公開日 | 2026年7月27日 |
概要
This is a validation study to evaluate the acceptability, feasibility and preliminary efficacy of the Brain Health Program, a multimodal curriculum covering dementia risk factors and evidence-based change interventions. The goal of this study is to evaluate the Brain Health Program in individuals with identified risk factors for the onset of dementia and to prepare for a large-scale efficacy trial in this population.
Net Promoter Score
| Brain Health Program | 65 score on a scale |
|---|
BENITIONS で見る ClinicalTrials.gov の原文を見る
同じ疾患の他の治験
- Brain Energy for Amyloid Transformation in Alzheimer's Disease Study — Wake Forest University Health Sciences
- Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss — Eli Lilly and Company
- Using a Wireless Controller to Deliver a Lighting Intervention to Persons With Dementia — Icahn School of Medicine at Mount Sinai
- Deprescribing in Patients Living With Dementia With Caregiver and Provider Nudges — Brigham and Women's Hospital
- Technology and Family Thriving Study — University of California, Santa Barbara
- Impact of Nilotinib on Safety, Biomarkers and Clinical Outcomes in Mild to Moderate Alzhei — Georgetown University